Paul Rennie
Amministratore Delegato presso PARADIGM BIOPHARMACEUTICALS LIMITED
Patrimonio netto: 3 M $ in data 31/05/2024
Profilo
Paul John Rennie is the founder of Paradigm Biopharmaceuticals Ltd., which was founded in 2014.
He currently holds the position of Executive Chairman & Managing Director at the company.
In addition to his founding position, Mr. Rennie has held former positions at Neuroscientific Biopharmaceuticals Ltd.
as Non-Executive Chairman from 2021 to 2023, Stiefel Research Australia Pty Ltd.
as Director-Business Development, Merck KGaA as National Manager-Sales Marketing, Bonlac Foods Ltd.
as Manager-Business Development, Mesoblast Ltd.
as Executive Vice President-New Product Development, and Roche Diagnostics Australia Pty Ltd.
as Manager-Sales & Marketing.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 29/02/2024 | 20 678 805 ( 5.90% ) | 3 M $ | 31/05/2024 |
Posizioni attive di Paul Rennie
| Società | Posizione | Inizio |
|---|---|---|
| PARADIGM BIOPHARMACEUTICALS LIMITED | Amministratore Delegato | 22/11/2022 |
Precedenti posizioni note di Paul Rennie
| Società | Posizione | Fine |
|---|---|---|
| NEUROSCIENTIFIC BIOPHARMACEUTICALS LIMITED | Amministratore Delegato | 11/09/2023 |
Stiefel Research Australia Pty Ltd.
 Stiefel Research Australia Pty Ltd. BiotechnologyHealth Technology Part of GSK Plc, Stiefel Research Australia Pty Ltd. is an Australian company that develops delivery systems for new dermatology products. The company is based in Rowville, Australia. Stiefel Research Australia was acquired by Connetics Corp. from FH Faulding & Co. Ltd. on April 23, 2001 for $15.93 million. | Corporate Officer/Principal | - |
| MERCK KGAA | Vendite & Marketing | - |
| Roche Diagnostics Australia Pty Ltd. | Vendite & Marketing | - |
| MESOBLAST LIMITED | Direttore operativo | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| MERCK KGAA | Health Technology |
| MESOBLAST LIMITED | Health Technology |
| NEUROSCIENTIFIC BIOPHARMACEUTICALS LIMITED | Health Technology |
| PARADIGM BIOPHARMACEUTICALS LIMITED | Health Technology |
| Aziende private | 3 |
|---|---|
Bonlac Foods Ltd.
 Bonlac Foods Ltd. Food DistributorsDistribution Services Bonlac Foods Ltd. manufactures dairy products and ingredients for domestic and international customers. The firm products include fresh & UTH milk, milk powders, cheese, spreads, fruit juice, sport drinks, and yoghurts. The company is located in Melbourne, Australia. | Distribution Services |
Stiefel Research Australia Pty Ltd.
Stiefel Research Australia Pty Ltd. BiotechnologyHealth Technology Part of GSK Plc, Stiefel Research Australia Pty Ltd. is an Australian company that develops delivery systems for new dermatology products. The company is based in Rowville, Australia. Stiefel Research Australia was acquired by Connetics Corp. from FH Faulding & Co. Ltd. on April 23, 2001 for $15.93 million. | Health Technology |
| Roche Diagnostics Australia Pty Ltd. |
- Borsa valori
- Insiders
- Paul Rennie
